Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
29,881,634
-
Total 13F shares
-
7,634,234
-
Share change
-
-91,787
-
Total reported value
-
$98,724,050
-
Put/Call ratio
-
56%
-
Price per share
-
$13.01
-
Number of holders
-
29
-
Value change
-
-$1,129,044
-
Number of buys
-
13
-
Number of sells
-
12
Institutional Holders of Profound Medical Corp. - Common Shares (PROF) as of Q2 2023
As of 30 Jun 2023,
Profound Medical Corp. - Common Shares (PROF) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,634,234 shares.
The largest 10 holders included
GAGNON SECURITIES LLC, FIL Ltd, LETKO, BROSSEAU & ASSOCIATES INC, Timelo Investment Management Inc., Gagnon Advisors, LLC, Raymond James Financial Services Advisors, Inc., ROYCE & ASSOCIATES LP, Royal Bank of Canada, BANK OF AMERICA CORP /DE/, and NATIONAL BANK OF CANADA /FI/.
This page lists
29
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.